MacColl, Christine
Stein, Nina
Tarnopolsky, Mark
Lu, Jian-Qiang http://orcid.org/0000-0003-1945-5569
Article History
Received: 4 June 2019
Accepted: 31 August 2019
First Online: 5 September 2019
Compliance with ethical standards
:
: Dr. Mark Tarnopolsky is the CEO of Exerkine Corporation and the company is working on therapies that target mitochondrial dysfunction; the remaining authors declare that they have no conflict of interest.